feed,title,long_url,short_url
Benzinga,"Ocugen Shares Sink Despite OCU200 Being Comparable To Aflibercept In Reducing Neovascularization, Damage To Retina In Animal Study",https://benzinga.com/general/biotech/21/05/20991300/ocugen-shares-sink-despite-ocu200-being-comparable-to-aflibercept-in-reducing-neovascularization-,https://j.mp/3tjq9LW
Benzinga,Moderna Stock Moves After Q1 Print: Technical Levels For The COVID-19 Vaccine Play,https://benzinga.com/general/biotech/21/05/20991510/moderna-stock-moves-after-q1-print-technical-levels-for-the-covid-19-vaccine-play,https://j.mp/3elqz02
